X-LINKED RETINITIS PIGMENTOSA
Clinical trials for X-LINKED RETINITIS PIGMENTOSA explained in plain language.
Never miss a new study
Get alerted when new X-LINKED RETINITIS PIGMENTOSA trials appear
Sign up with your email to follow new studies for X-LINKED RETINITIS PIGMENTOSA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Gene therapy offers hope for boys and men losing sight to rare eye disease
Disease control OngoingThis study tests a gene therapy called AGTC-501 in males aged 12 to 50 with X-linked retinitis pigmentosa, a genetic eye disease that slowly destroys vision. The treatment aims to improve low-light eyesight by delivering a working copy of the faulty RPGR gene. About 85 participan…
Matched conditions: X-LINKED RETINITIS PIGMENTOSA
Phase: PHASE2, PHASE3 • Sponsor: Beacon Therapeutics • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
Second-Eye gene therapy trial offers hope for rare vision loss
Disease control OngoingThis study tests a gene therapy given to the second eye of people with X-linked retinitis pigmentosa, a genetic condition that causes vision loss. About 24 adults and children who already received treatment in one eye will get the therapy in their other eye. Researchers will chec…
Matched conditions: X-LINKED RETINITIS PIGMENTOSA
Phase: PHASE2 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
Gene therapy aims to slow inherited blindness in long-term study
Disease control OngoingThis study tests a gene therapy for X-linked retinitis pigmentosa, an inherited eye disease that causes gradual vision loss. Researchers are checking if the treatment is safe and can help slow vision decline in 97 people aged 3 and older. The therapy uses a harmless virus to deli…
Matched conditions: X-LINKED RETINITIS PIGMENTOSA
Phase: PHASE3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated May 12, 2026 13:44 UTC